Abinash P. Achrekar

Abinash Achrekar practices at University of New Mexico Hospital in Albuquerque, New Mexico, part of The University of New Mexico.

Abinash Achrekar's NPI, 1669431201, was assigned on March 22, 2006. Abinash Achrekar graduated from Michigan State University College of Human Medicine in 2002. Abinash Achrekar holds New Mexico license MD2005-0182.

Abinash Achrekar's primary practice is University of New Mexico Hospital, at 2211 Lomas Boulevard NE, Albuquerque, NM 87106 in Bernalillo County. The practice phone is (505) 272-2111.

Abinash Achrekar's primary practice is University of New Mexico Hospital in Albuquerque, New Mexico, part of The University of New Mexico. Abinash Achrekar is also affiliated with Presbyterian Hospital. The medical group on file is UNM Medical Group, Inc.

Dmand AI tracks the electronic health record (EHR) system at each site where Abinash Achrekar practices, 2 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Abinash Achrekar's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Abinash Achrekar is licensed in New Mexico.

CMS data shows 1,334 Medicare services from Abinash Achrekar across 12 procedure codes in 2024, for 949 Medicare patients. Medicare paid $39,450 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 949 Medicare patients who saw Abinash Achrekar in 2024. The largest group is 65 to 74, with 363 patients. 75% of them have high blood pressure, and 69% have high cholesterol. 28% are also on Medicaid. Their average risk score is 1.90, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Abinash Achrekar's median patient age at 69, with 52% women.

In 2024, Abinash Achrekar wrote 790 Medicare Part D claims for 151 patients. 81% of them were for generic drugs. CMS names the drug for 635 of them, across 20 drugs with 11 or more claims each, at $136,632 in total drug cost. In 2023, CMS named 596 claims across 19 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 90 out of 100 for Abinash Achrekar for performance year 2024, reported as part of a group. Abinash Achrekar accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Abinash Achrekar as offering telehealth.

Dmand AI links 3 papers to Abinash Achrekar, published from 2016 to 2021. Abinash Achrekar's most frequent co-authors are David Edward Michalik, DO, Christopher James Rowan, MD and Kirsten Tolstrup.

CMS Open Payments shows 442 general payments to Abinash Achrekar from 32 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 74% of the total. Bristol-Myers Squibb Company paid the most, $89,249.

Abinash Achrekar graduated from Michigan State University College of Human Medicine in 2002.